Home
World Journal of Biology Pharmacy and Health Sciences
ISSN Approved | International, Peer reviewed, Referred, Open access Journal

Main navigation

  • Home
    • Journal Information
    • Abstracting and Indexing
    • Editorial Board Members
    • Reviewer Panel
    • Journal Policies
    • WJBPHS CrossMark Policy
    • Publication Ethics
    • Current Issue
    • Issue in Progress
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Become a Reviewer panel member
    • Join as Editorial Board Member
  • Contact us
  • Downloads

ISSN Approved Journal | | IMPACT FACTOR 8.16 | | eISSN: 2582-5542 | |  Free Crossref DOI 

Fast Publication within 2 days | | Low Article Processing Charges | | Peer Reviewed and Referred Journal

Research and review articles are invited for publication in September 2026 (Volume 27, Issue 3) Submit Paper

Optimal dual calcium and cholecalciderol dosages for osteoporotic fracture risk patients

Breadcrumb

  • Home
  • Optimal dual calcium and cholecalciderol dosages for osteoporotic fracture risk patients

Khaled Mohammad Juma Husain Bani Hani 1, *, Sinan Ibrahim Alghamaz 1, Madher Ali Mohammad Doumi 1, Rami Mohamad Salem Aldarawshe 1, Suhib Fayiz Naim Dawaghreh 1, Ahmed Mahmoud Mohammed Ali Alboun 2 and Kholoud Muhsen Al Quraan 3

1, Ahmed Mahmoud Mohammed Ali Alboun 2 and Kholoud Muhsen Al Quraan 3
1 Rehabilitation and rheumatology specialist, Royal Medical Services, Jordan.
2 Registered Nurse, Royal Medical Services, Jordan.
3 Lab Technician, Royal Medical Services, Jordan.

Research Article
 
World Journal of Biology Pharmacy and Health Sciences, 2024, 17(03), 205–220.
Article DOI: 10.30574/wjbphs.2024.17.3.0120
DOI url: https://doi.org/10.30574/wjbphs.2024.17.3.0120

Received on 01 March 2024; revised on 20 March 2024; accepted on 22 March 2024

Background: Vitamin D is crucial for musculoskeletal health, promoting calcium absorption, osteoid tissue mineralization, and muscle function. Insufficient levels can lead to bone dystrophy, muscle weakness, and osteoporotic fractures.
Aims: This research investigates the correlation between bone mineral density and osteoporotic fracture risk, including positive and negative influences, and aims to determine the optimal vitamin D level.
Methods: This retrospective observational study examined 206 Jordanian rehabilitation and rheumatology clinic patients from September to November 2021. The participants were post-menopausal women and men over 60. The Age-adjusted Charlson Co-Morbidity Index and Functionality Grade system was used to assess participants' co-morbidity burden and functionality. DEXA scans assessed participants' proximal femoral hip and anteroposterior spine. Participants were divided into two Vit D groups: those below 30 ng/ml and those above 30. Results were compared using a Chi Square test. The study examined correlations, total variations, and Vit D prediction quality using logistic regression analyses. SPSS 23.0 was used for statistical analysis with a 5% significance level.
Results: A binary logistic regression model was employed to simulate the correlation between the vitamin D levels of patients and their bone mineral density. The model indicated a 61.39% likelihood of having a fH_BMD (femoral head bone mineral density) equal to or greater than 0.755 g/cm2 when the vitamin D level is at its optimal value of 27.25 ng/ml. The model indicated a 27.25% likelihood of a fHOPF risk-free tool with a value of ≥3% when the optimal vitamin D level is 27.25 ng/ml. The model indicated a 17.74% likelihood of experiencing a significant osteoporotic fracture within the next 10 years.
Conclusion: The findings of our study demonstrated a direct correlation between elevated levels of vitamin D and improved bone mineral quality indices that were examined. The serum 25-OH Cholecalciferol levels are more likely to have a beneficial effect on bone health status.

Bisphosphonate; Vertebral fracture; Non-Vertebral fracture; Optimal threshold; Osteoporosis

https://wjbphs.com/sites/default/files/fulltext_pdf/WJBPHS-2024-0120.pdf

Preview Article PDF

Khaled Mohammad Juma Husain Bani Hani, Sinan Ibrahim Alghamaz, Madher Ali Mohammad Doumi, Rami Mohamad Salem Aldarawshe, Suhib Fayiz Naim Dawaghreh, Ahmed Mahmoud Mohammed Ali Alboun and Kholoud Muhsen Al Quraan. Optimal dual calcium and cholecalciderol dosages for osteoporotic fracture risk patients. World Journal of Biology Pharmacy and Health Sciences, 2024, 17(03), 205–220. Article DOI: https://doi.org/10.30574/wjbphs.2024.17.3.0120

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content


Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


Copyright © 2026 World Journal of Biology Pharmacy and Health Sciences (WJBPHS) - All rights reserved

Developed & Designed by VS Infosolution